NCT06775821

Brief Summary

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2024

Completed
8 months until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

January 15, 2025

Status Verified

January 1, 2025

Enrollment Period

2.6 years

First QC Date

May 19, 2024

Last Update Submit

January 11, 2025

Conditions

Keywords

Abdominal Aortic Aneurysmprimary lung cancerepidemiological studiesprevalence

Outcome Measures

Primary Outcomes (1)

  • Incidence of abdominal aortic aneurysm in patients with primary lung cancer

    Incidence of abdominal aortic aneurysm in patients with primary lung cancer

    2022-10-01 to 2025-04-30

Secondary Outcomes (1)

  • Epidemiological analysis

    2022-10-01 to 2025-04-30

Study Arms (1)

Primary lung cancer with concomitant abdominal aortic aneurysm

Device: Ultrasound or CT of the abdominal aorta

Interventions

Patient underwent ultrasound or CT of the abdominal aorta

Primary lung cancer with concomitant abdominal aortic aneurysm

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The selected subjects for the study were all patients diagnosed with primary lung cancer at the First Affiliated Hospital of Kunming Medical University and the Third Affiliated Hospital of Kunming Medical University from 1st October 2022 to 30 st April 2025, with an estimated sample size of about 2000 people. Detailed epidemiological data and long-term follow-up data were collected and analyzed, and epidemiological investigations were conducted.

You may qualify if:

  • Patients diagnosed with primary lung cancer through clinical or pathological examination

You may not qualify if:

  • Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, 650000, China

RECRUITING

The Third Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, 650000, China

RECRUITING

Related Publications (11)

  • Sakalihasan N, Michel JB, Katsargyris A, Kuivaniemi H, Defraigne JO, Nchimi A, Powell JT, Yoshimura K, Hultgren R. Abdominal aortic aneurysms. Nat Rev Dis Primers. 2018 Oct 18;4(1):34. doi: 10.1038/s41572-018-0030-7.

    PMID: 30337540BACKGROUND
  • Schanzer A, Oderich GS. Management of Abdominal Aortic Aneurysms. N Engl J Med. 2021 Oct 28;385(18):1690-1698. doi: 10.1056/NEJMcp2108504. No abstract available.

    PMID: 34706173BACKGROUND
  • Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019 Apr;16(4):225-242. doi: 10.1038/s41569-018-0114-9.

    PMID: 30443031BACKGROUND
  • Alnahhal KI, Urhiafe V, Narayanan M, Irshad A, Salehi P. Prevalence of abdominal aortic aneurysms in patients with lung cancer. J Vasc Surg. 2022 May;75(5):1577-1582.e1. doi: 10.1016/j.jvs.2021.09.037. Epub 2021 Oct 8.

  • Wiles B, Comito M, Labropoulos N, Santore LA, Bilfinger T. High prevalence of abdominal aortic aneurysms in patients with lung cancer. J Vasc Surg. 2021 Mar;73(3):850-855. doi: 10.1016/j.jvs.2020.05.069. Epub 2020 Jul 2.

  • Cho HJ, Yoo JH, Kim MH, Ko KJ, Jun KW, Han KD, Hwang JK. Risk of various cancers in adults with abdominal aortic aneurysms. J Vasc Surg. 2023 Jan;77(1):80-88.e2. doi: 10.1016/j.jvs.2022.03.896. Epub 2022 Jul 15.

  • Hohneck A, Shchetynska-Marinova T, Ruemenapf G, Pancheva M, Hofheinz R, Boda-Heggemann J, Sperk E, Riffel P, Michels J, Borggrefe M, Akin I, Sigl M. Coprevalence and Incidence of Lung Cancer in Patients Screened for Abdominal Aortic Aneurysm. Anticancer Res. 2020 Jul;40(7):4137-4145. doi: 10.21873/anticanres.14413.

  • Harthun NL, Lau CL. The incidence of pulmonary neoplasms discovered by serial computed tomography scanning after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2011 Mar;53(3):738-41. doi: 10.1016/j.jvs.2010.09.066. Epub 2010 Dec 3.

  • Lederlin M, Tredaniel J, Priollet P. [Why screen for lung cancer in patients with arterial disease?]. J Mal Vasc. 2015 Dec;40(6):359-64. doi: 10.1016/j.jmv.2015.07.001. Epub 2015 Aug 12. French.

  • Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014 Nov 1;35(41):2873-926. doi: 10.1093/eurheartj/ehu281. Epub 2014 Aug 29. No abstract available.

  • Scorza R, Ghilardi G, De Monti M, Sgroi G. [Current knowledge and unresolved problems in the pathogenesis of abdominal aortic aneurysm]. Minerva Cardioangiol. 1994 Sep;42(9):417-27. Italian.

Biospecimen

Retention: SAMPLES WITH DNA

Fresh AAA samples, fresh Ca lung samples, with organ donors normal aorta and lung tissue.

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Xu-Dong Xiang, MPhil

    The Third Affiliated Hospital of Kunming Medical University

    STUDY DIRECTOR
  • Ding-yun You, Ph.D.

    Kunming Medical University

    STUDY DIRECTOR
  • Yun-fei Shi, MPhil

    First Affiliated Hospital of Kunming Medical University

    STUDY DIRECTOR
  • Gui-ming Liu, MBBS

    The Third Affiliated Hospital of Kunming Medical University

    PRINCIPAL INVESTIGATOR
  • Qing-yan Ma, MBBS

    Kunming Medical University

    PRINCIPAL INVESTIGATOR
  • Qian Zhu, MBBS

    The Third Affiliated Hospital of Kunming Medical University

    PRINCIPAL INVESTIGATOR
  • Kai-xiong Qing, ph.D.

    The Third Affiliated Hospital of Kunming Medical University

    STUDY CHAIR

Central Study Contacts

Kai-xiong Qing, Ph.D.

CONTACT

Qian Zhu, MBBS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 19, 2024

First Posted

January 15, 2025

Study Start

October 1, 2022

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

January 15, 2025

Record last verified: 2025-01

Locations